Shan Man
Impact in
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
- Oncology top 0.5%
- Cancer Cells and Metastasis
- Cancer Treatment and Pharmacology
Papers in
- Oncology 53
- Cancer Cells and Metastasis 25
- Cancer Treatment and Pharmacology 13
- HER2/EGFR in Cancer Research 9
-
- Angiogenesis and VEGF in Cancer 38
- Co-authors
- Robert S. Kerbel (80 shared papers)Daniel J. Hicklin (14 shared papers)Yuval Shaked (26 shared papers)Giulio Francia (25 shared papers)Ping Xu (35 shared papers)Christina R. Lee (17 shared papers)Giannoula Klement (6 shared papers)Peter Böhlen (5 shared papers)
- Journals
- Cancer Research (19 papers)Clinical Cancer Research (9 papers)Molecular Cancer Therapeutics (7 papers)Angiogenesis (4 papers)Neoplasia (3 papers)
- Partner nations
- CanadaUnited StatesItaly
In The Last Decade
Shan Man
83 papers receiving 7.3k citations
Shan Man's Hit Papers
Peers
Comparison fields: 5 of 119
- Cancer Research 2.8k
- Oncology 3.7k
- Hepatology 534
- Biotechnology 529
- Molecular Biology 4.1k
Countries citing papers authored by Shan Man
This map shows the geographic impact of Shan Man's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan Man with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan Man more than expected).
Fields of papers citing papers by Shan Man
This network shows the impact of papers produced by Shan Man. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan Man. The network helps show where Shan Man may publish in the future.
Co-authors
The 25 scholars most cited alongside Shan Man, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity Hit paper breakdown → | 2000 | 956 |
| 2 | 2006 | 433 | |
| 3 | 2008 | 347 | |
| 4 | 2003 | 330 | |
| 5 | 2007 | 300 | |
| 6 | 2011 | 293 | |
| 7 | 2009 | 292 | |
| 8 | 2005 | 270 | |
| 9 | Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water. | 2002 | 264 |
| 10 | Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts. | 2002 | 202 |
| 11 | 2006 | 196 | |
| 12 | 2005 | 193 | |
| 13 | 2001 | 191 | |
| 14 | 2004 | 159 | |
| 15 | 2004 | 128 | |
| 16 | 2006 | 126 | |
| 17 | 2016 | 125 | |
| 18 | 2006 | 116 | |
| 19 | 2004 | 106 | |
| 20 | 2005 | 100 |
About Shan Man
Shan Man is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Hepatology, having authored 83 papers that have together received 7.5k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (38 papers), Cancer, Hypoxia, and Metabolism (27 papers), Cancer Cells and Metastasis (25 papers), Cancer Treatment and Pharmacology (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), HER2/EGFR in Cancer Research (9 papers), Cancer Research and Treatments (7 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Cancer Research (2.8k citations), Oncology (3.7k citations), Hepatology (534 citations), Biotechnology (529 citations) and Molecular Biology (4.1k citations). Shan Man has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include Robert S. Kerbel, Daniel J. Hicklin, Yuval Shaked, Giulio Francia, Ping Xu, Christina R. Lee, Giannoula Klement, Peter Böhlen, Urban Emmenegger and Janusz Rak. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Molecular Cancer Therapeutics, Angiogenesis and Neoplasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.